Kinetic Concepts Inc. wins FDA clearance for its next-generation negative-pressure wound therapy device, the V.A.C.Via.
Kinetic Concepts Inc. said it won 510(k) clearance from the FDA for a new negative-pressure wound therapy device, the V.A.C.Via, saying it plans to have it on the market in early December.
The V.A.C.Via is a portable wound care system featuring a diaphragm pump for faster draw down, longer battery life and a higher leak rate threshold, according to a press release.
"We’ve listened to the feedback from our customers and patients and have taken our original system and enhanced it to better meet their needs. The V.A.C.Via therapy unit is designed to help patients return to their normal lifestyle, while receiving up to 7 days of negative pressure wound therapy in a compact, portable unit," senior vice president Jim Cunniff said in prepared remarks.